Conclusions
lung cancer, SCLC
LUNG CANCER, SCLC
The two prognostic nomograms of SCLC including inflammatory markers, VALG stage, and other clinicopathological factors had good predictive value and could individually assess the survival of patients.We explored the relationship between pre‐treatment inflammatory markers and other clinical characteristics and the survival of small‐cell lung cancer (SCLC) patients who received first‐line platinum‐based treatment. The nomograms for predicting progression‐free survival and overall survival had good predictability and stability. This research may provide clues and guides for individual treatment of SCLC patients.
